Figure 7. Survival analysis of 365 HCC patients. High VEGF score subtype (A, B) and high activated CD8+ T cells (C, D) predicted favorable prognosis. Improved RFS and OS were observed in the VEGFHiCD8Hi group compared to the VEGFHiCD8Lo group and the VEGFLoCD8Lo group, but not the VEGFLoCD8Hi group (E, F).